U.S. biopharmaceutical developer Shattuck Labs raises $118 million in Series B funding
Summary
Shattuck Labs, a U.S. biopharmaceutical R&D company, raised $118 million in Series B funding. The article mainly centers on the financing event and places it in a broader news feed alongside other recent funding updates. No product release, acquisition, or leadership change is described in the text. The item is relevant to the life sciences and pharmaceutical sector rather than general technology news.
Funding
Amount
$118.0M
Total raised
Date
June 16, 2026
Announcement date
Investors
-
Lead investors
Company
shattucklabs.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected